Roche’s TNKase Revolutionizes Stroke Care with FDA Approval

added blog Health

2025-05-08 08:45:53

Roche has made history with the FDA approval of TNKase (tenecteplase), the first new acute ischemic stroke drug in nearly 30 years. The drug offers a faster, easier-to-administer alternative to existing stroke treatments and is set to change the standard of care for acute ischemic stroke (AIS) patients. This approval signifies a turning point in the evolution of acute ischemic...

0 Komen 0 Perkongsian 178 Views 0 review